XML 14 R4.htm IDEA: XBRL DOCUMENT v3.19.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
Income Statement [Abstract]        
Licensing revenue $ 125,000 $ 125,000 $ 250,000 $ 250,000
Operating expenses:        
Research and development 3,558,074 4,593,544 6,325,733 7,334,620
General and administrative 2,136,684 3,542,809 4,354,548 5,207,837
Total operating expenses 5,694,758 8,136,353 10,680,281 12,542,457
Loss from operations (5,569,758) (8,011,353) (10,430,281) (12,292,457)
Other (expense) income:        
(Loss) gain from change in valuation of earn-out milestone liability (127,061) (277,129) 3,002,939 (547,324)
Fair value of warrants issued in connection with amendment to modify GEN-1 earn-out milestone payments (400,000)
Investment income 144,602 73,461 258,393 147,185
Interest expense (349,448) (15,031) (700,195) (15,031)
Other (expense) income (2,850) (504) (2,823) 76
Total other (expense) income, net (334,757) (219,203) 2,158,314 (415,094)
Net loss $ (5,904,515) $ (8,230,556) $ (8,271,967) $ (12,707,551)
Net loss per common share        
Basic and diluted $ (0.29) $ (0.46) $ (0.42) $ (0.73)
Weighted average shares outstanding        
Basic and diluted 20,605,762 17,743,229 19,713,449 17,503,796